Authorised representative (AR)

KingSung Medical Biotechnology (Hongkong) Co., Limited

科创医疗生物科技(香港)有限公司
Hong Kong MDACS·13 represented devices·4 applicants·Nov 11, 2021Jun 24, 2024
13
Total devices
4
Applicants
2021
First representation
2024
Most recent
AR overview
Bilingual authorised representative information and contact details
Authorised representative (EN)
KingSung Medical Biotechnology (Hongkong) Co., Limited
Authorised representative (ZH)
科创医疗生物科技(香港)有限公司
Phone
27624861
Timeline
First representation
Nov 11, 2021
Most recent
Jun 24, 2024
Risk class distribution
II
2
III
10
IV
1
Applicant partnerships
Top manufacturers represented by this AR
Unknown Applicant
0
Recent registrations
Latest 15 MDACS listings represented by KingSung Medical Biotechnology (Hongkong) Co., Limited
DeviceRisk classApplicantRegistered
Orthopedic Internal Fixation Systems
骨科内固定系统
IIITriMed, Inc.
Trimed, Inc.
Jun 24, 2024
Anastomosis Couplers, Vascular
血管吻合器吻合器
IIISynovis Micro Companies Alliance Inc., a subsidiary of Synovis Life Technologies, Inc
Synovis Micro Companies Alliance Inc., a subsidiary of Synovis Life Technologies, Inc
Jun 06, 2024
Orthopedic Internal Fixation Systems, Fracture
骨科内固定系统,骨折
IIITriMed, Inc.
Trimed, Inc.
Jun 06, 2024
Clip Appliers, Vascular
夹子应用器,血管
II-Dec 22, 2023
Staplers, Skin
吻合器,皮肤
II-Dec 22, 2023
Anastomosis Couplers, Vascular
血管吻合器吻合器
III-Dec 15, 2023
Orthopedic Internal Fixation Systems
骨科内固定系统
III-Sep 14, 2023
Orthopedic Internal Fixation Systems
骨科内固定系统
IIITriMed, Inc.
Trimed, Inc.
Jan 04, 2023
Orthopedic Internal Fixation Systems
骨科内固定系统
IIITriMed, Inc.
Trimed, Inc.
Jan 04, 2023
Screws, Bone
螺丝,骨头
IIITriMed, Inc.
Trimed, Inc.
Jan 04, 2023
Orthopedic Internal Fixation Systems
骨科内固定系统
IIITriMed, Inc.
Trimed, Inc.
Jan 04, 2023
Plates, Bone
板,骨
IIITriMed, Inc.
Trimed, Inc.
Jan 04, 2023
Tissue Reconstructive Materials, Fluid
组织重建材料,液体
IVAdoderm GmbH
Adoderm GmbH
Nov 11, 2021
About this profile

KingSung Medical Biotechnology (Hongkong) Co., Limited serves as the authorised representative for 13 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.